Two Vaccine Targets on Virus May Be Better Than One

An experimental vaccine developed by GeoVax Labs succeeded in promoting development of antibodies that target two different sites on the virus in a small pilot study.
Reuters Health Information

source https://www.medscape.com/viewarticle/970179?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost